Eric Eross
Neurology · Phoenix, AZNPI 1063574572
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $593,386 of the $778,312 with a category attached, or 76.2%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.3%. Among neurology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,220 payments — averaging $637.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$142K
- Biohaven Pharmaceuticals, Inc.$122K
- Axsome Therapeutics, Inc.$107K
- AbbVie$96K
- Lilly USA, LLC$91K
- Amgen$58K
- plus $162K from 16 others
What the payments were for
- Consulting fees$133,04917%
- Speaking & faculty fees$593,38676%
- Grants$440%
- Travel & lodging$36,3775%
- Food & beverage$15,3182%
- Education$1380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 153 | $142,442 |
| Biohaven Pharmaceuticals, Inc. | 113 | $121,627 |
| Axsome Therapeutics, Inc. | 101 | $106,812 |
| AbbVie(2 entities) | 237 | $96,322 |
| Lilly USA, LLC | 149 | $91,339 |
| Amgen(2 entities) | 91 | $57,584 |
| Impel Pharmaceuticals Inc. | 80 | $53,688 |
| Lundbeck LLC | 96 | $51,763 |
| Teva Pharmaceuticals USA, Inc. | 61 | $28,309 |
| Pfizer | 110 | $21,241 |
| Novartis | 6 | $4,400 |
| Supernus Pharmaceuticals, Inc. | 7 | $2,542 |
| Scilex Pharmaceuticals Inc. | 5 | $88 |
| Abbott | 2 | $32 |
| Upsher-smith Laboratories LLC | 2 | $29 |
| Tempus AI, Inc | 1 | $28 |
| Boston Scientific | 1 | $15 |
| Tonix Medicines, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Impel Pharmaceuticals LLC | 1 | $6 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$778,312 in reported general payments places this provider in the 95th percentile of 388 neurology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 91 | $69,045 |
| Nurtec OdtRimegepant Sulfate | 27 | $50,432 |
| UbrelvyUbrogepant | 30 | $49,834 |
| QuliptaAtogepant | 26 | $34,784 |
| Aimovig AutoinjectorErenumab-Aooe | 30 | $27,824 |
| Emgality SyringeGalcanezumab-Gnlm | 18 | $25,348 |
| Sumatriptan Succinate | 124 | $4,833 |
| Topiramate ErTopiramate | 12 | $4,682 |
| Gabapentin | 83 | $2,604 |
| Diclofenac Potassium | 13 | $1,900 |
| Amitriptyline Hcl | 76 | $1,349 |
| Topiramate | 96 | $1,264 |
| Eletriptan HbrEletriptan Hydrobromide | 12 | $1,256 |
| Zolmitriptan | 23 | $1,236 |
| RizatriptanRizatriptan Benzoate | 34 | $1,020 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $96,322 | $84,61856 claims |
| PfizerNurtec Odt | $21,241 | $50,43227 claims |
| Upsher-smith Laboratories LLCTopiramate | $29 | $1,26496 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 388 neurology providers in Arizona.
Other neurology in Phoenix
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
- Kerry KnievelPhoenix$509K
- Lori TravisPhoenix$406K
- Jeffrey GittPhoenix$275K
- Todd SchwedtPhoenix$273K
- Joshua TobinPhoenix$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.